196 related articles for article (PubMed ID: 35873145)
1. A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma.
Chen J; Liu X; Qin S; Ruan G; Lu A; Zhang J; Wu Y; Xie Z; Peng J
Front Cell Infect Microbiol; 2022; 12():919446. PubMed ID: 35873145
[TBL] [Abstract][Full Text] [Related]
2. Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL.
Chen J; Wu Y; Zhao H; Ruan G; Qin S
Front Immunol; 2024; 15():1354325. PubMed ID: 38426083
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
Rapiti N; Abdelatif N; Moosa MS
PLoS One; 2022; 17(9):e0272282. PubMed ID: 36048870
[TBL] [Abstract][Full Text] [Related]
4. A new prognostic score for AIDS-related lymphomas in the rituximab-era.
Barta SK; Xue X; Wang D; Lee JY; Kaplan LD; Ribera JM; Oriol A; Spina M; Tirelli U; Boue F; Wilson WH; Wyen C; Dunleavy K; Noy A; Sparano JA
Haematologica; 2014 Nov; 99(11):1731-7. PubMed ID: 25150257
[TBL] [Abstract][Full Text] [Related]
5. A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era.
Chen J; Wu Y; Kang Z; Qin S; Ruan G; Zhao H; Tao X; Xie Z; Peng J
Cancer Med; 2023 Jun; 12(11):12470-12481. PubMed ID: 37081761
[TBL] [Abstract][Full Text] [Related]
6. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
8. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
Wyen C; Jensen B; Hentrich M; Siehl J; Sabranski M; Esser S; Gillor D; Müller M; Van Lunzen J; Wolf T; Bogner JR; Wasmuth JC; Christ H; Fätkenheuer G; Hoffmann C
AIDS; 2012 Feb; 26(4):457-64. PubMed ID: 22112600
[TBL] [Abstract][Full Text] [Related]
9. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.
Miralles P; Berenguer J; Ribera JM; Rubio R; Mahillo B; Téllez MJ; Lacruz J; Valencia E; Santos J; Rodríguez-Arrondo F; Pintado V;
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):167-73. PubMed ID: 17117144
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
[TBL] [Abstract][Full Text] [Related]
12. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
13. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
14. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
Wang C; Wu Y; Liu J; Min H; Huang Y; Wei G; Zhang W; Wang M; Tang X; Zhou H; Chen Y; Liu Y
Front Immunol; 2023; 14():1153790. PubMed ID: 37063928
[TBL] [Abstract][Full Text] [Related]
15. Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphoma.
Zhang J; Xie Z; Cai S; Qin S; Ruan G; Lu A; Wu Y; Chen J; Peng J
Infect Agent Cancer; 2022 Jun; 17(1):33. PubMed ID: 35717275
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
[TBL] [Abstract][Full Text] [Related]
17. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
Bower M; Gazzard B; Mandalia S; Newsom-Davis T; Thirlwell C; Dhillon T; Young AM; Powles T; Gaya A; Nelson M; Stebbing J
Ann Intern Med; 2005 Aug; 143(4):265-73. PubMed ID: 16103470
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
19. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.
Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Gómez J; Millá F; Feliu E
Haematologica; 1998 Jun; 83(6):508-13. PubMed ID: 9676023
[TBL] [Abstract][Full Text] [Related]
20. The clinical features and prognosis of 100 AIDS-related lymphoma cases.
Wu D; Chen C; Zhang M; Li Z; Wang S; Shi J; Zhang Y; Yao D; Hu S
Sci Rep; 2019 Mar; 9(1):5381. PubMed ID: 30926889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
